Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088983 | PMC |
Eur J Intern Med
January 2025
Service de Médecine Interne, Hôpital Bichat Claude Bernard, APHP, Université Paris Cité, Paris, France; CRI, INSERM UMR1149, CNRS ERL8252, Université Paris Cité, Laboratoire d'Excellence Inflamex, Paris, France. Electronic address:
J Am Coll Cardiol
January 2025
Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: https://twitter.com/DLBHATTMD.
Background: In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, most but not all randomized trials have reported that complete revascularization (CR) offers advantages over culprit vessel-only revascularization. In addition, the optimal timing and assessment methods for CR remain undetermined.
Objectives: The purpose of this study was to identify the optimal revascularization strategy in patients with STEMI and multivessel disease, using a network meta-analysis of randomized controlled trials.
J Arthroplasty
February 2025
Clinique de l'Union, Saint-Jean, France.
Intensive Care Med
January 2025
Medical and Infectious Diseases Intensive Care Unit, Bichat Claude Bernard University Hospital, Université Paris Cité, AP-HP, Paris, France.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!